Table 4.

Relationship between Baseline BP and Mortality from Kidney Cancer Over an Average Follow-up of 25 Years in the MRFIT Cohort.

Baseline	Number of Men	Deaths from Kidney Cancer		Unadjusted HR (95% CI)	Adjusted HR* (95% CI)
		N	%
SBP (mmHg)
<120	88,641	165	0.19	1.00	1.00
120–129	100,168	241	0.24	1.33 (1.09–1.62)	1.29 (1.06–1.58)
130–139	80,582	233	0.29	1.64 (1.34–2.01)	1.52 (1.25–1.86)
140–149	45,171	129	0.29	1.69 (1.34–2.13)	1.48 (1.17–1.86)
150–159	21,889	78	0.36	2.22 (1.69–2.91)	1.82 (1.39–2.40)
>160	16,889	60	0.36	2.41 (1.79–3.25)	1.87 (1.38–2.53)
DBP (mmHg)
<80	118,857	255	0.21	1.00	1.00
80–84	79,312	198	0.25	1.18 (0.98–1.43)	1.16 (0.97–1.40)
85–89	58,358	175	0.30	1.44 (1.19–1.75)	1.41 (1.16–1.71)
90–94	46,541	147	0.32	1.55 (1.27–1.90)	1.49 (1.21–1.83)
95–99	24,716	61	0.25	1.24 (0.94–1.64)	1.19 (0.90–1.58)
≥100	25,556	70	0.27	1.46 (1.12–1.91)	1.39 (1.06–1.81)